Skip to content

Author

Kathryn D. Smith

We have 1 of 22 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

Abstract IA05: Eliminating the oncogenic driver: Advancing targeted degradation of KRAS

Oral pan-KRAS degraders are supported as a differentiated therapeutic approach for KRAS-driven cancers, with potential advantages in monotherapy activity, durability, immune engagement, and tolerability relative to pan-RAS targeting.

Kathryn D. Smith · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.